Alerts will be sent to your verified email
Verify EmailRPTECH
|
Rashi Peripheral
|
Novartis
|
A-1
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
20.68 % | 8.0 % | 7.49 % |
|
5yr average Equity Multiplier
|
3.51 | 2.72 | 1.51 |
|
5yr Average Asset Turnover Ratio
|
3.35 | 0.18 | 3.75 |
|
5yr Avg Net Profit Margin
|
1.65 % | 17.12 % | 1.32 % |
|
Price to Book
|
1.25 | 2.78 | 40.44 |
|
P/E
|
10.15 | 20.22 | 588.99 |
|
5yr Avg Cash Conversion Cycle
|
49.08 Days | -23.33 Days | 45.58 Days |
|
Inventory Days
|
44.68 Days | 44.27 Days | 2.84 Days |
|
Days Receivable
|
41.61 Days | 38.18 Days | 44.79 Days |
|
Days Payable
|
40.24 Days | 124.28 Days | 2.55 Days |
|
5yr Average Interest Coverage Ratio
|
4.37 | 65.43 | 5.16 |
|
5yr Avg ROCE
|
32.55 % | 5.91 % | 12.1 % |
|
5yr Avg Operating Profit Margin
|
2.88 % | 15.15 % | 2.33 % |
|
5 yr average Debt to Equity
|
1.05 | 0.0 | 0.38 |
|
5yr CAGR Net Profit
|
9.8 % | 37.01 % | 5.98 % |
|
5yr Average Return on Assets
|
5.6 % | 3.13 % | 4.79 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
63.79 % | 70.68 % | 70.03 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.38 % | 0.0 | 0.03 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
4.18 % | 0.0 | 0.0 |
|
Rashi Peripheral
|
Novartis
|
A-1
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Distribution Channel
|
Distribution Channel
|
-
|
-
|